AstraZeneca Profit Beats Estimates on Cancer, Diabetes Drugs

Published on November 6, 2025

AstraZeneca Plc’s profit rose more than analysts anticipated last quarter, buoyed by demand for its blockbuster cancer and diabetes drugs.